Alexandre Ferro Aissa

15PUBLICATIONS
49CO-AUTHORS
Molecular targetsCancer cell biologyChemotherapyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 24, 2026
Sulfonylated Goniothalamin and Piplartine Derivatives Exhibit Selective Antiproliferative Activity on Breast Cancer Cells via Oxidative Stress-Mediated Mechanisms.

|Jan 13, 2026
Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition.

Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos

|Aug 18, 2025
Unraveling the Effects of Epigallocatechin-3-gallate on Hepatocellular Carcinoma Cells: A Comparative Analysis of Monolayer vs Multicellular Tumor Spheroids.

Mariana Dos Reis Simpronio, Ana Rita Thomazela Machado, Patrick Santos

|Aug 14, 2025
Toxigenomic Evaluation of Diallyl Disulfide Effects and Its Association with the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cell Lines.

Estefani Maria Treviso, Caroline Andolfato Sanchez, Cecília Cristina Souza Rocha

|Feb 15, 2025
HDAC6 inhibition through WT161 synergizes with temozolomide, induces apoptosis, reduces cell motility, and decreases β-catenin levels in glioblastoma cells.

Leilane Sales Oliveira, João Marcos Oliveira-Silva, Hebreia Oliveira Almeida-Souza

|Jan 17, 2025
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

João Marcos Oliveira-Silva, Leilane Sales Oliveira, Carolina Berraut Chiminazo

Pageof 3

Frequent Collaborators

6 joint publications

Lusânia Maria Greggi Antunes

4 joint publications

Marisa Ionta

3 joint publications

Hidayatullah G Munshi

2 joint publications

Carla Machado